Laboratory products
Σ–MM™ Inactivation Media
Oct 05 2021
Inactivates SARS-CoV-2 in 60 seconds
Designed and manufactured in the UK, Σ–MM™ solution rapidly kills all microorganisms, including bacteria, mycobacteria and viruses, rendering specimens safe for transport, whilst preserving and stabilising RNA/DNA for accurate molecular analysis across diagnostic platforms.
Key Benefits
- Inactivates SARS-CoV-2 in 60 seconds
- Rapidly kills all microorganisms, including bacteria, mycobacteria and viruses
- Suitable for highly infectious clinical specimens
- DNases and RNases inactivated
- DNA and RNA preserved for molecular testing
- Can be used with any swab
- Powerful reagents kill deadly pathogens quickly
- Safe and stable for transport at ambient temperature
The Σ–MM™ device is a highly effective single step collection. The medium disturbs and lyses lipid membranes, destroys proteins including DNase and RNase, leaving stable intact DNA or RNA. Specimens collected into Σ–MM™ can be transported at ambient temperatures, no freezing or refrigeration is required. Specimens can be collected using any microbiology swabs, including MWE Transwab® and all MWE Dryswab™ products.
Σ–MM™ has been on the market for a number of years and has consistently been shown to effectively eliminate infectious microorganisms from specimens. During the pandemic, Σ–MM™ has demonstrated compatibility on numerous PCR platforms, where samples were rendered safe for handling & viral RNA was preserved, resulting in accurate diagnostic reporting.
A study was designed in cooperation with the Medical Research Council & University of Glasgow’s Centre for Virus Research to measure the inactivation of SARS-CoV-2 achieved in specimens collected using Σ–MM™. Σ–MM™ Molecular Medium was tested for the ability to inactivate SARS- CoV-2-Gla-1 isolate.
BS EN 14476 requires that there should be a titre reduction of more than 4 log10 for virucidal suspension tests. Σ–MM™ consistently exceeded this requirement for both the time points and concentrations used in the study. In fact, in 1 minute of inoculation there was no detectable virus at all in 6 out of 6 samples tested. Given that the test concentrations were higher than would be the case for clinical specimens, the study demonstrates that Σ–MM™ can be used as a safe transport system for SARS-CoV-2 specimens, offering rapid inactivation. The results are consistent with other studies using different inactivation reagents and methods.
Digital Edition
Lab Asia 31.6 Dec 2024
December 2024
Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...
View all digital editions
Events
Jan 22 2025 Tokyo, Japan
Jan 22 2025 Birmingham, UK
Jan 25 2025 San Diego, CA, USA
Jan 27 2025 Dubai, UAE
Jan 29 2025 Tokyo, Japan